Immunoassay Market to Reach $61.6 Billion, Globally, by 2033 at 5.8% CAGR | DiaSorin S.p.A., Thermo Fisher Scientific, Inc., BioMerieux SA, Abbott Laboratories

According to the report, the immunoassay market was valued at $35.0 billion in 2023, and is estimated to reach $61.6 billion by 2033, growing at a CAGR of 5.8% from 2024 to 2033.

Request Sample of the Report on:

https://www.alliedmarketresearch.com/request-sample/939

Rise in incidences of chronic diseases, favorable regulatory scenario, and increase in geriatric population are the major factors that drive the growth of the immunoassay market growth. However, high development and manufacturing costs hinder market growth. Moreover, technological advancements and untapped markets in developing economies offer remunerative opportunities for the expansion of the global immunoassay market.

Connect to our Analyst -

https://www.alliedmarketresearch.com/connect-to-analyst/939

The hospitals and clinics segment to maintain its leadership status during the forecast period

By end user, hospitals and clinics widely utilize immunoassay technology due to its versatility, accuracy, and rapid results. Immunoassays enable healthcare providers to perform a wide range of diagnostic tests, including disease screening, monitoring, and prognosis, enhancing patient care and treatment decision-making within clinical settings.

For Purchase Related Queries/Inquiry -

https://www.alliedmarketresearch.com/purchase-enquiry/939

Regional Outlook

In North America there is a robust market for immunoassay due to advanced healthcare systems, rise in prevalence of chronic disease conditions, and greater accessibility to healthcare services. These regions also witness significant research and development activities, leading to the advancement in immunoassay technology. In emerging markets such as Asia-Pacific and LAMEA the immunoassay market is experiencing rapid growth driven by increasing healthcare expenditure and expanding pharmaceutical industries.

Key Players

F. Hoffmann-La Roche Ltd.
Danaher Corporation
Abbott Laboratories
Siemens Healthineers (Siemens AG)
DiaSorin S.p.A.
Sysmex Corporation
BioMerieux SA
Ortho Clinical Diagnostics
Thermo Fisher Scientific, Inc.,
Becton, Dickinson and Company
Merck kGaA

Get Customized Reports with your Requirements -

https://www.alliedmarketresearch.com/request-for-customization/939

The report provides a detailed analysis of these key players in the global immunoassay market. These players have adopted different strategies such as expansion, product approval, product launch and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.

Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.

This release was published on openPR.